Testogel Dosiergel 16 clinical trials

Comparative Bioavailability and Bioequivalence of Testosterone Transdermal Gel Versus Testogel® Dosiergel 16.2 mg/g gel: A Single-Dose, Open-Label, Randomized, Full Replicate, Four-Period Crossover Study in Healthy Female Subjects Under Fasting Conditions.

This study compares a new testosterone gel with an existing one. We want to see if they both deliver similar amounts of testosterone into the body of healthy women. This helps ensure new gels work as expected for men with low testosterone.